Literature DB >> 8703694

Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population.

A Fuchshuber1, P Niaudet, O Gribouval, G Jean, M C Gubler, M Broyer, C Antignac.   

Abstract

Congenital nephrotic syndrome of the Finnish type (CNF) is inherited as an autosomal recessive trait. The biochemical basis of the disease is unknown, although a lesion in the glomerular basement membrane is strongly suggested. Recently, the CNF locus was assigned to chromosome 19q12-q13.1 on the basis of linkage analysis in Finnish families. The high incidence of the disease in Finland, as well as the demonstration of linkage disequilibrium in the Finnish study, strongly suggests a founder effect based on a common ancient mutation in this population. We confirm linkage of the CNF locus to the same chromosomal region in seven non-Finnish CNF families without evidence of linkage disequilibrium. Our results show that the same gene seems to be affected in both Finnish and non-Finnish CNF populations. However, in the latter the mutation-carrying chromosomes descend from different ancestors without evidence of a founder effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703694     DOI: 10.1007/BF00862052

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

2.  Congenital nephrotic syndrome of Finnish type. Study of 75 patients.

Authors:  N P Huttunen
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

3.  Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19.

Authors:  M Kestilä; M Männikkö; C Holmberg; G Gyapay; J Weissenbach; E R Savolainen; L Peltonen; K Tryggvason
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

4.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

Review 5.  Disease gene mapping in isolated human populations: the example of Finland.

Authors:  A de la Chapelle
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

6.  Exclusion of eight genes as mutated loci in congenital nephrotic syndrome of the Finnish type.

Authors:  M Kestilä; M Männikkö; C Holmberg; K Korpela; E R Savolainen; L Peltonen; K Tryggvason
Journal:  Kidney Int       Date:  1994-04       Impact factor: 10.612

7.  Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker.

Authors:  H G Harley; J D Brook; J Floyd; S A Rundle; S Crow; K V Walsh; M C Thibault; P S Harper; D J Shaw
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

8.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

9.  Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor.

Authors:  G R Dressler; E C Douglass
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  LODVIEW: a computer program for the graphical evaluation of lod score results in exclusion mapping of human disease genes.

Authors:  F Hildebrandt; A Pohlmann; H Omran
Journal:  Comput Biomed Res       Date:  1993-12
View more
  11 in total

1.  Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites.

Authors:  S Bolk; E G Puffenberger; J Hudson; D H Morton; A Chakravarti
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  A novel nonsense mutation in NPHS1: is aortic stenosis associated with congenital nephropathy?

Authors:  Lara Gharibeh; Inaam El-Rassy; Ayman Soubra; Raya Safa; Akl Fahed; Rachel Tanos; Mariam Arabi; Zakaria Kambris; Fadi Bitar; Georges Nemer
Journal:  J Genet       Date:  2015-06       Impact factor: 1.166

3.  Management of congenital nephrotic syndrome.

Authors:  Larisa Kovacevic; Christopher J D Reid; Susan P A Rigden
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

4.  Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families.

Authors:  J M Savage; J A Jefferson; A P Maxwell; A E Hughes; J H Shanks; D Gill
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

5.  Congenital nephrotic syndrome responsive to captopril and indometacin.

Authors:  P A Heaton; O Smales; W Wong
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 6.  Genetic forms of nephrotic syndrome.

Authors:  Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

7.  No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations.

Authors:  Michael Schultheiss; Rainer G Ruf; Bettina E Mucha; Roger Wiggins; Arno Fuchshuber; Anne Lichtenberger; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

8.  Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients.

Authors:  Bugsu Ovunc; Shazia Ashraf; Virginia Vega-Warner; Detlef Bockenhauer; Neveen A Soliman Elshakhs; Mark Joseph; Friedhelm Hildebrandt
Journal:  Nephron Clin Pract       Date:  2012-05-11

9.  Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy.

Authors:  William Wong; Maxwell Clarke Morris; Tonya Kara
Journal:  Pediatr Nephrol       Date:  2013-08-15       Impact factor: 3.714

10.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.

Authors:  U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.